Uniqure N.V. (QURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | QURE | URGN | ADCT | ||
| Company | Uniqure N.V. | Urogen Pharma Ltd | Adc Therapeutics Sa | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 5.79 | 12.15 | 2.96 | ||
| High | 5.89 | 12.33 | 3.11 | ||
| Low | 5.52 | 11.84 | 2.86 | ||
| Last | 5.56 | 11.93 | 3.02 | ||
| Change | -0.30 | -0.27 | +0.07 | ||
| % Change | -5.12% | -2.21% | +2.37% | ||
| Volume | 612,600 | 345,300 | 363,800 | ||
| 20-Day Average Volume | 730,480 | 770,295 | 344,375 | ||
| Previous Close | 5.86 | 12.20 | 2.95 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.11 | 12.37 | 3.01 | ||
| 20-Day Raw Stochastic | 16.18% | 27.08% | 48.48% | ||
| 20-Day Relative Strength | 45.54% | 42.41% | 49.63% | ||
| Weighted Alpha | -53.10 | -26.02 | +67.13 | ||
| Today's Opinion | 32% Sell | 100% Sell | 80% Sell | ||
| Previous Opinion | 24% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 8% Sell | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.77% since 10/28/24 | -1.81% since 10/28/24 | -1.31% since 10/28/24 | ||
| Low | 5.52 on 11/04/24 | 11.84 on 11/04/24 | 2.81 on 10/31/24 | ||
| High | 6.73 on 10/29/24 | 13.33 on 10/30/24 | 3.11 on 11/04/24 | ||
| 1-Month | |||||
| %Chg | -1.59% since 10/04/24 | -6.06% since 10/04/24 | -8.21% since 10/04/24 | ||
| Low | 5.03 on 10/07/24 | 11.30 on 10/09/24 | 2.70 on 10/11/24 | ||
| High | 7.27 on 10/28/24 | 13.64 on 10/14/24 | 3.45 on 10/07/24 | ||
| 3-Month | |||||
| %Chg | -23.94% since 08/02/24 | -23.92% since 08/02/24 | +4.86% since 08/02/24 | ||
| Low | 4.45 on 10/03/24 | 11.30 on 10/09/24 | 2.53 on 08/12/24 | ||
| High | 7.77 on 08/07/24 | 16.19 on 08/15/24 | 3.45 on 10/07/24 | ||
| 6-Month | |||||
| %Chg | +18.55% since 05/03/24 | -16.57% since 05/03/24 | -38.37% since 05/03/24 | ||
| Low | 3.73 on 07/05/24 | 10.60 on 05/13/24 | 2.45 on 06/26/24 | ||
| High | 11.35 on 07/10/24 | 20.70 on 06/14/24 | 5.17 on 05/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 285,370 | 286,139 | 285,230 | ||
| Shares Outstanding, K | 48,698 | 23,454 | 96,688 | ||
| Annual Sales | 15,840,000 | 82,710,000 | 69,560,000 | ||
| Annual Net Income | -308,480,000 | -102,240,000 | -240,050,000 | ||
| Last Quarter Sales | 11,130,000 | 21,850,000 | 17,410,000 | ||
| Last Quarter Net Income | -56,300,000 | -33,400,000 | -36,540,000 | ||
| 60-Month Beta | 0.90 | 1.12 | 1.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 08/01/24 | -0.91 on 08/13/24 | -0.38 on 08/06/24 | ||
| Latest Earnings Date | 11/05/24 | 11/06/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||